title: Metronomic chemoimmunotherapy in a patient with refractory Waldenstrom's macroglobulinemia.
authors.forename: Athanasios B-T
authors.initials: AB
authors.lastname: Fassas
authors.forename: Elias
authors.initials: E
authors.lastname: Kiwan
authors.forename: Jennifer
authors.initials: J
authors.lastname: Roberts
authors.forename: Tammy
authors.initials: T
authors.lastname: Burr
authors.forename: Guido
authors.initials: G
authors.lastname: Tricot
authors.forename: Elias
authors.initials: E
authors.lastname: Anaissie
authors.forename: Bart
authors.initials: B
authors.lastname: Barlogie
mesh_terms: D000368:Aged; D000074323:Alemtuzumab; D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D061067:Antibodies, Monoclonal, Humanized; D000912:Antibodies, Neoplasm / Q000627:therapeutic use; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D006801:Humans; D007155:Immunologic Factors / Q000627:therapeutic use*; D008297:Male; D016879:Salvage Therapy / Q000379:methods; D016896:Treatment Outcome; D008258:Waldenstrom Macroglobulinemia / Q000188:drug therapy*
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000912:Antibodies, Neoplasm; D007155:Immunologic Factors; D000074323:Alemtuzumab